ArticleFrontiers in cellular and infection microbiology2022

Design of a Bispecific HIV Entry Inhibitor Targeting the Cell Receptor CD4 and Viral Fusion Protein Gp41.

Hongxia Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.